We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,380
Increased
6,046
Reduced
2,042
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONDW
9801
DELISTED
Sonder Holdings Inc Warrants
SONDW
$2 ﹤0.01%
400
UUU icon
9802
Universal Safety Products Inc
UUU
$11M
$2 ﹤0.01%
1
-35,708
-100% -$67.2K
VIGL
9803
DELISTED
Vigil Neuroscience
VIGL
$2 ﹤0.01%
1
-282
-100% -$833
WKSP icon
9804
Worksport
WKSP
$9.71M
0
YGMZ
9805
DELISTED
MingZhu Logistics Holdings
YGMZ
0
EMCGR
9806
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
$1 ﹤0.01%
18
EMCGW
9807
DELISTED
Embrace Change Acquisition Corp Warrants
EMCGW
$1 ﹤0.01%
+100
New +$2
PASG icon
9808
Passage Bio
PASG
$14.4M
0
PTIXW
9809
DELISTED
Protagenic Therapeutics Warrant
PTIXW
$1 ﹤0.01%
+360
New +$3
FTH
9810
Faeth Therapeutics
FTH
$702M
0
UNCY icon
9811
Unicycive Therapeutics
UNCY
$137M
0
YTRA icon
9812
Yatra Online
YTRA
$52.7M
$1 ﹤0.01%
1
GDSTR
9813
DELISTED
Goldenstone Acquisition Limited Rights
GDSTR
$1 ﹤0.01%
+16
New +$3
PPYAW
9814
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$1 ﹤0.01%
66
NMHIW
9815
DELISTED
Natures Miracle Holding Inc. Warrants
NMHIW
$1 ﹤0.01%
40
AAPX icon
9816
T-Rex 2X Long Apple Daily Target ETF
AAPX
$9.21M
-19
Closed -$657
ABEQ icon
9817
Absolute Select Value ETF
ABEQ
$143M
-3,873
Closed -$127K
ACON icon
9818
Aclarion
ACON
$5.54M
-4
Closed -$7.32K
ACR
9819
ACRES Commercial Realty
ACR
$124M
-168
Closed -$2.63K
ACWI icon
9820
CALL
iShares MSCI ACWI ETF
ACWI
$32.9B
-1,507,808
Closed -$180M
ADIV icon
9821
Guinness Atkinson Asia Pacific Dividend Builder ETF
ADIV
$54.7M
-2
Closed -$33
AEE icon
9822
CALL
Ameren
AEE
$30.3B
-300,000
Closed -$26.2M
AFIF icon
9823
Anfield Universal Fixed Income ETF
AFIF
$227M
-5,056
Closed -$46.6K
AFK icon
9824
VanEck Africa Index ETF
AFK
$99.3M
-1,562
Closed -$26.2K
AFMC icon
9825
First Trust Active Factor Mid Cap ETF
AFMC
$189M
-1,661
Closed -$53.5K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.